Literature DB >> 20721643

The "antiphospholipid triangle" in an asymptomatic patient: a case report.

Antonella Tufano, Anna Guida, Anna Maria Cerbone, Giovanni Di Minno.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20721643     DOI: 10.1007/s11739-010-0441-2

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  5 in total

1.  International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).

Authors:  S Miyakis; M D Lockshin; T Atsumi; D W Branch; R L Brey; R Cervera; R H W M Derksen; P G DE Groot; T Koike; P L Meroni; G Reber; Y Shoenfeld; A Tincani; P G Vlachoyiannopoulos; S A Krilis
Journal:  J Thromb Haemost       Date:  2006-02       Impact factor: 5.824

2.  Antibody profiles for the diagnosis of antiphospholipid syndrome.

Authors:  Vittorio Pengo; Alessandra Biasiolo; Cinzia Pegoraro; Umberto Cucchini; Franco Noventa; Sabino Iliceto
Journal:  Thromb Haemost       Date:  2005-06       Impact factor: 5.249

3.  Aspirin in asymptomatic patients with confirmed positivity of antiphospholipid antibodies: only in selected, high risk patients.

Authors:  Mario Bazzan; Antonella Vaccarino
Journal:  Intern Emerg Med       Date:  2008-12-12       Impact factor: 3.397

4.  The antiphospholipid triangle.

Authors:  M Galli
Journal:  J Thromb Haemost       Date:  2009-11-13       Impact factor: 5.824

5.  Clinical course of high-risk patients diagnosed with antiphospholipid syndrome.

Authors:  V Pengo; A Ruffatti; C Legnani; P Gresele; D Barcellona; N Erba; S Testa; F Marongiu; E Bison; G Denas; A Banzato; S Padayattil Jose; S Iliceto
Journal:  J Thromb Haemost       Date:  2009-10-30       Impact factor: 5.824

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.